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Structure of MHC class I-like MILL2 reveals
heparan-sulfate binding and interdomain ﬂexibility
Mizuho Kajikawa1,2, Toyoyuki Ose3, Yuko Fukunaga2, Yuki Okabe2,3, Naoki Matsumoto4, Kento Yonezawa5,
Nobutaka Shimizu5, Simon Kollnberger6, Masanori Kasahara7 & Katsumi Maenaka 2,3
The MILL family, composed of MILL1 and MILL2, is a group of nonclassical MHC class I
molecules that occur in some orders of mammals. It has been reported that mouse MILL2 is
involved in wound healing; however, the molecular mechanisms remain unknown. Here, we
determine the crystal structure of MILL2 at 2.15 Å resolution, revealing an organization
similar to classical MHC class I. However, the α1-α2 domains are not tightly ﬁxed on the α3-
β2m domains, indicating unusual interdomain ﬂexibility. The groove between the two helices
in the α1-α2 domains is too narrow to permit ligand binding. Notably, an unusual basic patch
on the α3 domain is involved in the binding to heparan sulfate which is essential for MILL2
interactions with ﬁbroblasts. These ﬁndings suggest that MILL2 has a unique structural
architecture and physiological role, with binding to heparan sulfate proteoglycans on ﬁbro-
blasts possibly regulating cellular recruitment in biological events.
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C lassical major histocompatibility complex class I (MHC-I)molecules (e.g. human HLA-A, B, C, mouse H-2K, D, L)are highly polymorphic glycoproteins associated with β2-
microglobulin (β2m), expressed on the cell surface of nucleated
cells. The main function of classical MHC-I molecules is the cell-
surface presentation of peptides, derived from the degradation of
cytosolic proteins, to CD8+ cytotoxic T cells1. The extracellular
region of MHC-I heavy chains comprises α1, α2, and α3
domains2. The membrane-distal α1-α2 domains form two α-
helices bordering an anti-parallel β-sheet platform2. Cytosolic
peptides bind in the groove formed between these helices2. T cell
receptors on CD8+ cytotoxic T cells recognize cognate peptide-
MHC complexes at the cell surface3. During CD8+ cytotoxic T
cell activation, the CD8 co-receptor can enhance interactions with
classical MHC-I by binding to the α3 domain4,5. If the bound
peptide is derived from a foreign antigen or abnormal self-pro-
tein, CD8+ cytotoxic T cells are activated to eliminate the cells1.
Hence, classical MHC-I molecules are key proteins in the adap-
tive immune system in vertebrates. The high degree of poly-
morphic variation in amino acids in the peptide-binding groove
increases the repertoire of peptides bound by MHC-I at the
population level.
Mammalian genomes also incorporate MHC-I-like non-
classical MHC-I genes6. Overall the three-dimensional structures
of nonclassical MHC-I molecules resemble classical MHC-I7.
Although some nonclassical MHC-I molecules display peptides in
grooves formed by their α1-α2 domains, these molecules also
have additional roles which are not just restricted to the peptide
presenting function of classical MHC-I to T cells8. HLA-E binds
peptides derived from the leader sequence of classical MHC-I for
cell surface expression and interacts with CD94/NKG2 receptors
on NK cells and T cells9,10. In addition, other nonclassical MHC-I
molecules bind low-molecular-weight non-peptide ligands in the
grooves between the α1-α2 domains, which, in many cases,
determines their unique function. Microbial vitamin B metabo-
lites bound to MR1 molecules activate mucosal-associated
invariant T (MAIT) cells11,12. The CD1 family presents glycoli-
pids to αβ T cells or NKT cells13. On the other hand, some
nonclassical MHC-I molecules do not apparently bind any low-
molecular-weight ligands in the α1-α2 groove14–18. Thus,
whether ligands bind in the groove formed by the α1-α2 domains
plays a critical role in determining the function of nonclassical
MHC-I.
We identiﬁed a nonclassical MHC-I gene family designated as
MILL (MHC-I-like located near the leukocyte receptor complex)
in the genomes of rodents19,20, marsupials21 and odd-toed
ungulates20. The members of this family, MILL1 and MILL2,
are cell surface β2m-associated GPI-anchored glycoproteins22,23.
MILL1 is exclusively expressed in immune-related tissues, such as
thymus and skin, whereas MILL2 is found at very low levels on
several different tissues19,20,22. The expression level of MILLs is
independent of the function of transporter associated with anti-
gen processing (TAP)22, indicating that cytosolic peptides are not
required for their assembly at the cell surface. Thus, MILLs are
not involved in peptide antigen presentation to CD8+ cytotoxic
T cells. Phylogenetic analysis indicates that the MILL family is
most closely related to the human MIC family19–21,24, which
binds to NKG2D25. Furthermore, rodents lack MIC genes and
conversely, humans do not have Mill genes19–21,24. This obser-
vation suggested that the MILL family, acting as the counterpart
for the human MIC family in rodents, might activate NK cells
through binding to NKG2D. However, mouse MILL proteins
were subsequently shown not to bind to NKG2D23. Instead of
typical immunological roles, MILLs were reported to be involved
in nutrient metabolism and wound healing in mice23. These
ﬁndings suggest that MILL molecules have distinct functions
from classical MHC-I and MIC molecules; however, the physio-
logical roles of MILLs remain largely unknown.
In this study, we present the crystal structure of mouse MILL2
at 2.15 Å resolution. Surprisingly, two conformations of MILL2
with a large difference in domain orientation are observed. One
conformation is essentially similar to typical MHC-I molecules,
whereas, in the other, the α1-α2 domains are located distantly
from the α3-β2m domains exposing the interface between the α1-
α2 and α3-β2m domains. This structural diversity indicates that
the α1-α2 domains of MILL2 can associate with β2m plastically.
On the other hand, the tight proximity of the two helices formed
by the α1-α2 domains leaves too little space to bind ligand. Based
on these observations, we speculate that MILL2 presumably plays
no role in ligand presentation at the cell surface. Interestingly, we
ﬁnd a remarkable basic patch on the β-strand of α3 domain,
which is a unique feature of MILL2 compared with other MHC-I.
Based on the MILL2 tetramer-staining assay, we show that this
basic patch in the α3 domain forms a binding site for heparan
sulfate (HS) on the surface of NIH-3T3 cells, indicating that
heparan sulfate proteoglycans (HSPGs) on ﬁbroblasts may be
physiological ligands for MILL2.
Results
Structural determination of mouse MILL2. Previous study has
shown that, although bacterially expressed recombinant MILL2
refolds in isolation, β2m facilitates refolding efﬁciency22. The
extracellular domain of MILL2 was therefore reconstituted with
β2m. The heterodimer complex of refolded MILL2 with β2m was
subjected to size-exclusion chromatography (Supplementary
Fig. 1a), followed by cation-exchange chromatography (Supple-
mentary Fig. 1b). Highly puriﬁed MILL2 that had a 1:1 stoichio-
metry with β2m (Supplementary Fig. 1c) was used for
crystallization screening. Crystals of MILL2 were obtained in
buffer containing polyethylene glycol 3350 and sodium sulfate
(Supplementary Fig. 1d). X-ray diffraction data were collected up
to 2.15 Å. The structure was solved by the molecular replacement
method using the crystal structure of human hemochromatosis
protein (PDB ID: 1A6Z) as a search model. Supplementary
Table 1 presents a summary of the statistics for structural
reﬁnement. A section of the 2Fo-Fc electron density map is shown
in Supplementary Fig. 1e.
MILL2 can adopt two distinct conformations. Unexpectedly,
two different conformations of MILL2 were observed in the
asymmetric crystal unit (Supplementary Fig. 2). The overall
structure of one conformation closely resembled other typical
MHC-I molecules2 harboring three domains (α1, α2, and α3)
with β2m (Fig. 1a and Supplementary Fig. 2, chains in purple
(MILL2) and green (β2m)). The α1 and α2 domains, composed of
residues 6–179, have two anti-parallel α-helices lying on an anti-
parallel β-sheet platform formed by seven β-strands (Supple-
mentary Fig. 3). In ligand-presenting MHC-I molecules, small
molecules bind in the groove formed between these α1 and α2
helices7. The α3 domain, composed of residues 188–275, is
annotated as an immunoglobulin-like C1 domain19 (Supple-
mentary Fig. 3). Similar to other β2m-associated MHC-I, β2m was
located to the side of this domain (Supplementary Fig. 3). Five N-
terminal MILL-speciﬁc residues and the loop formed by residues
179–183 were not observed in this structure, suggesting that they
are disordered.
In the second conformation, each domain exhibits a structure
similar to the typical MHC-I domains; however, the α1-α2
domains do not associate with β2m (Fig. 1a, Supplementary Fig. 2,
3, chains in magenta (MILL2) and yellow (β2m)). Superimposi-
tion of the typical closed conformation and the unique open
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conformation clearly shows that the α1-α2 domains are located
far from the α3-β2m domains in the open conformation (Fig. 1a).
MILL2 is the ﬁrst β2m-associated MHC-I molecule shown to
form both open and closed conformations. To date, all β2m-
associated MHC-I molecules have been reported to form the
closed conformation with the α1-α2 domains typically ﬁxed onto
the α3-β2m domains by tight contact with β2m (Fig. 1b, left). On
the other hand, the α1-α2 domains of β2m-free MHC-I molecules
(e.g. human MICA and MICB) form open conformations because
the α1-α2 domains are no longer anchored in the absence of β2m,
(Fig. 1b, right)14,26. The existence of both open and closed
conformations for MILL2 indicates that, although the α1-α2
domains associate with β2m, this interaction is not of sufﬁciently
high avidity to maintain a constitutive association (Fig. 1b,
center).
Small angle X-ray scattering (SAXS) proﬁles of MILL2 were
compared with theoretically calculated scattering curves of both
the open and the closed conformation from the crystal structures
(Supplementary Fig. 4). It shows good agreement with the closed
conformation with the chi-square value of 0.989. The SAXS
experimental conditions and the resultant values of analysis are
summarized in Supplementary Table 2.
A similar number of residues are involved in contacts between
MILL2 and β2m compared to those formed by classical mouse
MHC-I, H-2Db (PDB ID: 1CE6)27 (Supplementary Data 1). Thirty
contact residues are found between H-2Db and β2m in the H-2Db/
β2m complex, whereas 30 residues form contacts between MILL2
and β2m in the closed conformation of MILL2 (Supplementary
Data 1). The binding surfaces with β2m are very similar between
MILL2 and H-2Db. Contact residues on β2m are also well
conserved; however, those on the heavy chains are not (Fig. 1c, d
and Supplementary Fig. 5a, b). In particular, on the α1-α2
domains, only three of a total of 30 contact residues are conserved
between H-2Db and MILL2 (Supplementary Data 1). In addition,
there are signiﬁcantly fewer van der Waals interactions in the
MILL2/β2m complex (Supplementary Data 1). Whereas H-2Db
forms 201 van der Waals interactions with β2m, MILL2 forms
only 165 interactions (Supplementary Data 1). In particular, the
α1-α2 domains of H-2Db form 108 interactions but the
corresponding domains of MILL2 form only 97 (Supplementary
Data 1). These results demonstrate that although MILL2 associates
with β2m by the same interface, the molecular packing between
MILL2 and β2m is less tight than that of classical MHC-I.
In H-2Db, the main contact sites on the α3 domain are
concentrated in a region between Arg234 and Gln24228. In the
corresponding region of MILL2, contacts with Pro238, Gly240,
Asp241 and Gln245 were conserved (Supplementary Data 1).
Multiple van der Waals interactions and hydrogen bonds with
β2m were observed in this region of MILL2 (Supplementary
Data 1), suggesting that the interactions of the α3 domain with
β2m are sufﬁciently strong for anchoring β2m without the need
for additional interactions with the α1-α2 domains.
Narrow spacing of the two helices in the α1-α2 domains. The
top view of MILL2 is shown in Fig. 2. The two helices in the α1-
α2 domains are very close to each other (Fig. 2a). The distance
between the two helices of the α1-α2 domains is much smaller
than that of classical MHC-I (PDB ID: 1E27) (Fig. 2b). The space
between the two helices in classical MHC-I is large enough to
permit binding of cytosolic peptides (Fig. 2e). By contrast, the
interhelical space of MILL2 is ﬁlled with amino acid side chains
from both helices (Fig. 2d). Such narrow interhelical spacing i-
s also observed for NKG2D ligand members, which do not pre-
sent ligands for their function, e.g. human MICB (PDB ID:
1JE6)26 (Fig. 2f). Notably, the space between the α1-α2 helices is
narrower than the corresponding space in MICB (Fig. 2c). Thus,
it is unlikely that ligands are bound in the groove formed between
the two helices of the α1-α2 domains in MILL2, and the phy-
siological function of MILL2 is unlikely to be related to ligand
presentation.
Two remarkable basic patches on MILL2. Electrostatic analysis
revealed that both conformations of MILL2 have a basic patch
between the two helices of the α1-α2 domains (Supplementary
Fig. 6a, b). This patch is formed by Arg65, Lys72, Lys76, His169,
and Arg172 of MILL2 (Supplementary Fig. 7a). The amino acid
sequences of MILLs are most closely related to human MICA and
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Fig. 1 MILL2 crystals form both closed and open conformations. a The
closed conformation (left), open conformation (center), and
superimposition of these two conformations based on the position of β2m
chain (right) are represented by ribbon diagrams. Purple, closed
conformation of MILL2; magenta, open conformation of MILL2; green, β2m
associated with the closed conformation of MILL2; yellow, β2m associated
with the open conformation of MILL2. b Schematic model of the ﬂexible
membrane-distal α1-α2 domains (center). In typical β2m-associated MHC-I
molecules, the α1–α2 domains have no ﬂexibility because of tight
interactions with β2m (left). By contrast, the α1–α2 domains of β2m–free
MHC-I molecules (e.g. human MIC family) are located far from the
membrane-proximal α3 domain. c Surface model of MILL2 showing contact
residues with β2m. Orange, conserved contact residues with β2m on MILL2
and H-2Db; cyan, MILL2-speciﬁc contact residues with β2m. β2m is
represented by a transparent ribbon diagram (green). d Surface model
showing contact residues on β2m with MILL2. Orange, contact residues on
β2m conserved between MILL2 and H-2Db; cyan, MILL2-speciﬁc contact
residues on β2m. MILL2 heavy chains are represented by a ribbon diagram
(purple)
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MICB19 which activate NK cells by binding to the NKG2D
receptor. However, human MIC and other NKG2D family ligands
have an acidic patch on the top of the α1-α2 domains29,30
(Supplementary Fig. 8). Electrostatic interactions between
NKG2D and its ligands are important for NK cell activation29,30.
Thus, the presence of a basic patch in MILLs in place of the
characteristic acidic patch of NKG2D ligands provides a plausible
explanation for their lack of interaction with this receptor23.
Interestingly, electrostatic analysis also revealed another large
basic patch located on the exposed surface of the α3 domain in
both closed and open conformations (Fig. 3a, b). This region is
composed of Arg194, Arg200, Lys229, Arg232, Arg247 and
Arg251 (Supplementary Fig. 7b). Because these basic patches are
unique to MILL2 among all MHC-I superfamily members, we
hypothesized that these two remarkable basic patches are
involved in the physiological functions of MILL2. The physiolo-
gical receptor(s) of MILL2 remain(s) unknown. However,
recombinant MILL2 Fc-fusion protein (MILL2-Fc) binds to the
cell surface of the mouse NIH-3T3 ﬁbroblast cell line23. Our
MILL2 tetramer also bound to this cell line (Supplementary
Fig. 9) . Trypsin treatment of the cell surface completely abolished
tetramer binding (Supplementary Fig. 9), suggesting that NIH-
3T3 cells express a putative cell surface receptor for MILL2. In
order to determine the possible involvement of the basic patches
on the molecule in binding to NIH-3T3 cells, we generated
MILL2-tetramers with alanine-substitutions of the arginine and
lysine residues forming these regions. Substitutions of K72A+
K76A and R65A+ R172A were selected to change the basic patch
in the α1-α2 domains, whereas substitutions of R194A+ R200A
+ R251A and K229A+ R232A+ R247A were generated to
change the basic patch in the α3 domain. K72A+ K76A and
R65A+ R172A mutant tetramers bound to the cell surface of
NIH-3T3 cells similar to wild type MILL2 tetramer (Fig. 3c). By
contrast, R194A+ R200A+ R251A and K229A+ R232A+
R247A mutagenesis completely abrogated tetramer binding to
NIH-3T3 cells (Fig. 3c). The structural stability of these mutants
was conﬁrmed by size exclusion chromatography (Supplementary
Fig. 10). While Arg247 binds to β2m, K229A+ R232A+ R247A
mutagenesis did not lose the association with β2m (Supplemen-
tary Fig. 10). Hence, these results suggest that the unusual basic
patch in the α3 domain is a potential binding site for the putative
receptor on NIH-3T3 cells.
MILL2 binds to heparan sulfate proteoglycans. In the crystal
structure of MILL2, a SO4 ion from the crystallization buffer is
located on the edge of the unique basic patch in the α3 domain,
proximal to Arg251 (Fig. 3d). Highly basic patches on protein
surfaces can bind to the HS moiety of HSPGs, which are nega-
tively charged glycosaminoglycans31–33. We reasoned that this
observation gave some indication of the physiological ligand for
MILL2 and hypothesized that MILL2 could bind to HS through
the basic patch located on the surface of the α3 domain. Con-
sistent with MILL2 binding to HS, MILL2 tetramers did not bind
to NIH-3T3 cells after treatment with the HS-speciﬁc endogly-
cosidases heparinase I and III (Fig. 3e). In addition, soluble
heparin blocked MILL2 tetramer binding to NIH-3T3 cells
(Fig. 3f). Furthermore, cell surface trypsinization of NIH-3T3
cells completely abolished tetramer binding (Supplementary
Fig. 9). These results suggest that MILL2 binds to cell surface
HSPGs on ﬁbroblast cells.
We performed heparin afﬁnity chromatography to determine
whether MILL2 interacts directly with heparan sulfate. Wild type
MILL2 bound to heparin agarose and was eluted with 410 mM
NaCl (Fig. 4a, b). Interestingly, although the heavy chain bound
to heparin agarose, β2m dissociated from the heavy chain and
eluted in the ﬂow-through fraction (Fig. 4b). On the other hand,
the R194A+ R200A+ R251A mutant, whose tetramer does not
bind to the surface of NIH-3T3 cells (Fig. 3c), hardly bound to the
column, and mainly eluted in the ﬂow-through fraction (Fig. 4a,
b). Any small quantities of bound mutant MILL2 eluted at the
lower concentration of NaCl (130 mM) compared to wild type
MILL2 (Fig. 4a and b). We next studied interaction of an MHC-I
molecule, which lacks the basic patch found in MILL2 (HLA-G,
Supplementary Fig. 11) to heparin agarose. HLA-G did not bind
to the column (Fig. 4a, b). These results strongly support that
MILL2 directly and speciﬁcally binds to heparan sulfate at the
basic patch in the α3 domain.
Discussion
In this study, we determined the three-dimensional structure of
mouse MILL2 by X-ray crystallography. The domain structures of
MILL2 are similar to those of MHC-I molecules which typically
associate with β2m. However, distinct structural features shed
light on interesting and unique functions of MILL2. Notably, an
a b c
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Fig. 2 The narrow space between the two helices in α1-α2 domains of MILL2. a Top view of the membrane-distal α1-α2 domains of MILL2 represented by a
ribbon diagram (purple). b, c Superimposition of MILL2 α1-α2 domains with b HLA-B (PDB ID: 1E27) or c MICB (PDB ID: 1JE6), represented by ribbon
diagrams. Purple, MILL2; cyan, HLA-B; yellow, MICB. d–f Side view of the α1-α2 domains of d MILL2, e HLA-B (PDB ID: 1E27), and f MICB (PDB ID: 1JE6)
represented by cutaway model. Purple, MILL2; cyan, HLA-B; yellow, MICB
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Fig. 3 Putative heparan sulfate-binding site on the α3 domain of MILL2. a, b Side views of a the open and b the closed conformation of MILL2 shown by a
ribbon diagram (left) and its electrostatic surface potential model (right). Magenta and yellow indicate open conformation of MILL2 and β2m, respectively.
Purple and green indicate closed conformation of MILL2 and β2m, respectively. Red and blue indicate negatively and positively charged areas, respectively.
The black dotted circles highlight the position of the basic patch. c Histograms show the binding levels of MILL2 and the respective alanine-substituted
tetramers to NIH-3T3 cells. PE-conjugated MILL2 tetramer and tetramers incorporating alanine substitutions in the basic patch of the α1-α2 domains
(K72A+ K76A and R65A+ K172A) or α3 domain (R194A+ R200A+ R251A, K229A+ R232A+ R247A) were generated. Staining with PE-conjugated
streptavidin (shaded histograms) or PE-conjugated tetramer (open histograms) was measured by ﬂow cytometry. d An SO4 ion is located near the basic
patch on the α3 domain in MILL2 crystals. The α3 domain of MILL2 is shown as a ribbon diagram (purple) and sticks represent the side chains of residues
in this patch. The SO4 ion is shown as a space-ﬁlling model. e Histograms show staining of NIH-3T3 cells with wild type MILL2 tetramers with or without
heparinase treatment. Cells were preincubated with PBS (control) or PBS including heparinase (heparinase). After treatment, cells were stained with PE-
conjugated streptavidin (green histogram) or PE-conjugated MILL2 tetramer (pink histogram) and binding was measured by ﬂow cytometry. f Histogram
shows heparin-competition for the binding of MILL2 tetramers to NIH-3T3 cells. PE-conjugated streptavidin (green histogram) or PE-conjugated MILL2
tetramer (pink histogram) staining was performed with heparin. Binding was measured by ﬂow cytometry
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unusual basic patch on the α3 domain of MILL2 bestows HS
binding capacity.
Firstly, our structural analysis indicates MILL2 associates with
β2m; however, the interaction between the α1-α2 domains of
MILL2 and β2m is not as strong as other β2m-associated MHC-I
(Fig. 1a). β2m-associated MHC-I molecules are not stably
expressed at the cell surface in the absence of β2m34. Among the
MHC-I superfamily, AZGP1, MICA, MICB and other NKG2D
ligands form β2m-free MHC-I molecules, which do not require
β2m for their correct folding and function. Some NKG2D ligand
family members (i.e. Rae-1, H60 and ULBP) even lack an α3
domain. In the case of MILL2, although β2m associates with
endogenous MILL2 and increases refolding efﬁciency, it is not
essential for refolding in vitro22. Moreover, MILL2 is expressed
on the cell surface of β2m-deﬁcient cell lines23. These observa-
tions indicate that β2m is not required for the structural stability
of MILL2. In this study, MILL2 adopted two alternative con-
formations in crystals (Fig. 1a and Supplementary Fig. 2). The
presence of an open conformation suggested that, although β2m
does associate with the α1-α2 domains of MILL2, this structure is
not as ﬁxed as other β2m-associated MHC-I (Fig. 1a). The resi-
dues at the interface between MHC-I molecules and β2m are
highly conserved among all MHC superfamily members which
associate with β2m28. However, many of these residues are not
conserved in the MILL2 heavy chain (Fig. 1c). Moreover, the
number of physical interactions with β2m is also signiﬁcantly
fewer than those seen with classical MHC-I (Supplementary
Data 1). These observations suggest that β2m supports MILL2
rather than forming an essential element of its structure. SAXS
analysis shows that the majority of MILL2 in solution exists in the
closed conformation (Supplementary Fig. 4). The closed con-
formation may be advantageous for keeping MILL2 stability in
solution. However, the crystal packing deﬁnitely indicates the
presence of the open conformation is not the result of inter-
ference of the neighboring molecules (Supplementary Fig. 2).
Interestingly, binding to heparin by the basic patch on MILL2
released β2m (Fig. 4), indicating that heparin-bound MILL2
adopts the open conformation. The close contacts required for
strong binding to heparan sulfate may make it necessary to
change the conformation from closed to open by releasing β2m.
Therefore, our ﬁndings suggest that the conformational ﬂexibility
observed here is physiological and further elucidation of its
functional signiﬁcance will be required in future work.
Secondly, the space between the two helices in the α1-α2
domains was too narrow to permit binding of peptides or small
ligands which typically associate with MHC-I (Fig. 2d). MHC-I
molecules which bind peptide generally do not refold in the
absence of peptide, because peptide-binding is believed to stabi-
lize the structure of the α1-α2 domains of MHC-I35. We have
previously demonstrated that MILL2 successfully refolds without
any peptides or other small ligands22. In this study, MILL2 was
successfully crystallized in the absence of small molecule ligands.
We therefore speculate that, similar to the human MIC family,
MILL2 does not bind peptides or small ligands in the groove
formed by the α1-α2 domains.
Thirdly, we report the identiﬁcation of an important basic
patch on the α3 domain which mediates binding to HS on the cell
surface of ﬁbroblast cell lines. Electrostatic analysis of the crystal
structure of MILL2 identiﬁed two unique basic patches at the
surface of the α1-α2 and α3 domains (Fig. 3a, b and Supple-
mentary Figs. 6, 7). Alanine-substitution of lysine or arginine
residues in these patches revealed that the basic patch on the α3
domain is essential for MILL2 tetramer binding to NIH-3T3 cells
(Fig. 3c). In addition, heparinase and protease treatment revealed
that MILL2 tetramers bind to HSPGs on the surface of NIH-3T3
cells (Fig. 3e, f and Supplementary Fig. 9). Notably, a SO4 ion
from the crystallization buffer bound to the basic patch on the α3
domain in crystals (Fig. 3d). Taken together, these ﬁndings sup-
port that the charge–charge interactions between the basic patch
on the α3 domain and the HS moiety of HSPGs on ﬁbroblast cells
mediate binding. In this study we report an MHC family member
with a unique basic patch on the α3 domain (Supplementary
Fig. 11). In both the open and closed conformations, the basic
patch on the α3 domain surface is mainly composed of the fourth
Elution volume (ml)
a
b
10
15
20
25
37
50
(kDa)
HC
β2m
F/W
0 10 20 30 40
0 10 20 30 40
0
0
2
4
6
8
10
0
1
2
3
0
1
2
3
10 20 30 40
HL
A-G
Wi
ld 
typ
e
R1
94
A+
R2
00
A+
R2
51
A
F/W Peak F/W Peak
Flow through/Wash
A2
80
 (m
AU
)
A2
80
 (m
AU
)
A2
80
 (m
AU
) HLA-G
Wild type
R194A+R200A+R251A
Flow through/Wash
Flow through/Wash 1 M NaCl
0 M
1 M NaCl
0 M
1 M NaCl
0 M
Fig. 4 MILL2 binds directly to heparin. a Heparin afﬁnity chromatography. MILL2 (Wild type or R194A+ R200A+ R251A) or HLA-G was loaded on a
HiTrap Heparin HP column equilibrated with 20mM Tris-HCl buffer pH 8.0. Subsequently, column were washed with 20 column volumes of 20mM Tris-
HCl buffer pH 8.0 and bound proteins were eluted with 20 column volumes of a linear NaCl gradient (0 to 1M NaCl in 20mM Tris-HCl buffer pH 8.0).
Open arrowheads indicate peaks eluted by the NaCl gradient. b SDS-PAGE analysis of collected ﬂow-through/wash fraction (F/W) and eluted peak
fraction (Peak). Arrows indicate heavy chain (HC) or β2m. An uncropped scanned image of this gel is shown in Supplementary Fig. 15
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-06797-8
6 NATURE COMMUNICATIONS |  (2018) 9:4330 | DOI: 10.1038/s41467-018-06797-8 | www.nature.com/naturecommunications
and ﬁfth β-strand of this domain (Supplementary Fig. 12a).
Lys229 and Arg232 are located on the fourth β-strand, and
Arg247 and Arg251 are on the ﬁfth β-strand (Supplementary
Fig. 12a). Interestingly, classical MHC-I molecules have a long
loop (known as the CD loop) instead of a fourth β-strand
(Supplementary Fig. 12c). The CD loop is the most important
region for association with the CD8 co-receptor36,37. By contrast
with MILL2, the region corresponding to the ﬁfth β-strand in
classical MHC-I molecules is buried beneath the CD loop (Sup-
plementary Fig. 12b). However, the ﬁfth β-strand in the MILL2
α3 domain is exposed to solvent because the location of the fourth
strand makes the ﬁfth strand accessible (Supplementary Fig. 12b).
All reported MHC-I structures have the classical MHC-I type CD
loop, supporting that the basic patch on this MILL2-speciﬁc
strand is a unique structure for speciﬁc binding of HS. To date,
CD85,36,37, LILRs38, PIRs39 and Ly49s40–42 are also known as the
α3-associating MHC receptors; however, receptor binding to
basic patches on MHC heavy chains is a unique mode of inter-
action. The binding of MILL2 to HS by a basic patch on the α3
domain therefore constitutes a yet another binding mode for
MHC-I family member receptors which has not been previously
reported.
It was previously reported that MILL2 could be involved in
nutrient metabolism23. MILL2 binding to bone marrow cells was
reduced by the presence of some polyamines (i.e., spermine and
spermidine) or fetal bovine serum (FBS)23. This phenomenon
suggests that effects of MILL2 on nutrient metabolism are
modulated by binding to serum factors23. The present ﬁnding,
namely the binding of MILL2 to HSPGs, suggests that positively
charged polyamines or serum factors may competitively inhibit
the interaction between the basic patch on the α3 domain and
complementary negatively charged HS.
The physiological role and cognate receptor(s) for the other
MILL family member, MILL1, are unknown. The amino acid
identity of the extracellular domains of MILL1 and MILL2 is
70%19. Our previous report revealed that whereas β2m was not
required for the folding of MILL2, it was essential for correct
folding of MILL122. Moreover, endogenous MILL1 is not
expressed on thymic stromal cells from β2m-deﬁcient mice22.
These ﬁndings indicate that association with β2m is essential to
stabilize the structure of MILL1. Amino acid sequence compar-
isons indicate that residues in the α2 and α3 domains which bind
β2m are well conserved, whereas many of the residues that bind
β2m in the α1 domain differ between MILL1 and MILL2 (Sup-
plementary Fig. 13). It is possible that strong interactions in the
α1 domain of MILL1 with β2m stabilize its structure. On the other
hand, MILL1 lacks several amino acid residues that form the basic
patch on the MILL2 α3 domain (Supplementary Fig. 14). Our
tetramer binding assays revealed that the wild type MILL1 tet-
ramer does not bind to NIH-3T3 cells (Supplementary Fig. 9).
Although previous reports demonstrated that MILL1-Fc fusion
protein could bind to NIH-3T3 cells, the degree of binding was
much lower than for MILL2-Fc fusion protein23. These results
suggest that cell surface HSPGs on NIH-3T3 cells are not phy-
siological ligands for MILL1.
In this study, we successfully identiﬁed HS as a ligand for
MILL2, shedding light on the physiological role of MILL2. Many
types of HSPGs are expressed on ﬁbroblasts, epithelial cells and as
part of the extracellular matrix31,32. The interactions between
HSPGs and their ligands or receptors are involved in multiple
biological pathways in vivo (e.g., cell growth, inﬂammation and
wound healing)31,32. Indeed, Ravinovich et al. demonstrated that
administration of a MILL2-speciﬁc monoclonal antibody
enhances wound healing in the skin23. The syndecan family of
HSPGs are key molecules in wound healing43–46. Thus, it is
plausible that MILL2 binding to HS on syndecans could play an
important role in the recruitment of MILL2-expressing cells to
ﬁbroblasts by utilizing HS and HSPGs, in a way that is similar to
many other signaling systems, such as TGF-β, FGF and Wnt.
Identiﬁcation of HSPGs associated with MILL2 and investigation
of the role of their interaction in controlling the mobility or
proliferation of ﬁbroblasts are likely to lead to a further under-
standing of the physiological functions of MILL2.
Methods
Expression of recombinant MILL2 and β2m. The extracellular domains of mouse
MILL2 and mouse β2m were expressed individually in E. coli strain BL21 (DE3)
pLysS (Agilent) using the pGMT7 expression vector47. DNA fragments were
obtained by PCR using the BALB/c mouse cDNAs as templates19. The primer
sequences that incorporated PshBI and HindIII sites to facilitate cloning are shown
in Supplementary Table 3. The forward primer for MILL2 introduced synonymous
codon changes destabilizing secondary structure formation by mRNA. PCR pro-
ducts were digested with PshBI/HindIII and ligated to the NdeI/HindIII-digested
pGMT7 vector (hereafter designated as pGMT7-MILL2 and pGMT7-β2m). In all
cases, the integrity of expression constructs was veriﬁed by sequencing analysis.
Plasmid DNAs for transformation were isolated with the plasmid puriﬁcation kit
purchased from QIAGEN. To express recombinant MILL2 and β2m, pGMT7-
MILL2 or pGMT7-β2m were individually transformed into E. coli strain, BL21
(DE3) pLysS. Recombinant proteins were expressed as inclusion bodies by adding
isopropyl-1-thio-β-D-galactopyranoside. Five hours after induction, cells were
harvested and lysed by sonication in suspension buffer containing 1% Triton X-
100, 50 mM Tris-HCl (pH 8.0) and 150 mM NaCl. Inclusion bodies of over-
expressed protein were obtained by centrifugation at 7000 × g for 10 min at 4 °C.
Isolated inclusion bodies were denatured by solubilization buffer containing
50 mM Tris-HCl (pH 8.0), 6 M guanidine hydrochloride, 100 mM NaCl and
10 mM EDTA. Denatured inclusion bodies were stored at −80 °C until
use.
Refolding and puriﬁcation of soluble MILL2/β2m heterodimer. Soluble MILL2/
β2m complexes were prepared by rapid dilution refolding. Firstly, denatured
inclusion bodies of β2m with 10 mM DTT were diluted in refolding buffer (0.1 M
Tris-HCl (pH 8.0), 0.4 M L-arginine-HCl, 6.5 mM cysteamine, and 3.7 mM
cystamine) to a ﬁnal protein concentration of 10 μM with gently stirring for 48 h at
4 °C. Successfully refolded β2m was puriﬁed by size-exclusion chromatography
with HiLoad 26/60 SuperdexTM 75 prep grade (GE Healthcare). Subsequently,
denatured inclusion bodies of MILL2 with 10 mM DTT were diluted in refolding
buffer with 10 μM refolded β2m to a ﬁnal MILL2 protein concentration of 1 μM
with stirring for 48 h at 4 °C. Successfully refolded complexes of MILL2/β2m were
puriﬁed by size-exclusion column chromatography using a HiLoad 26/60 Super-
dexTM 75 prep grade column and then cation-exchange column chromatography
using RESOURCE S (GE Healthcare). The fraction corresponding to the MILL2/
β2m complex was collected and concentrated to 9.5 mg ml−1 in 10 mM HEPES-
NaOH (pH 7.0) for crystallization.
Crystallization and structural determination. Crystals of MILL2 were grown at
20 °C by the hanging drop vapor-diffusion method. The ﬁnal crystallization con-
dition was 0.1 M BIS-Tris propane·HCl (pH 8.5), 20% (w/v) polyethylene glycol
3350, and 0.2 M sodium sulfate. For data collection, crystals were soaked in crys-
tallization buffer supplemented with 25% ethylene glycerol, and then ﬂash frozen in
a cryostream at 100 K. The ﬁnal data set was collected at beamline BL17A of
Photon Factory (Tsukuba, Japan) using an ADSC CCD detector Q270. The dif-
fraction data set was integrated, merged, and scaled with the HKL2000 program
package48. The structure was solved by the molecular replacement method using
the Molrep program49. Structure reﬁnement was carried out using Phenix50. The
stereochemical properties of the structure were assessed using Molprobity51 and
COOT52. Figures of structural information were prepared with PyMOL 1.4 (http://
pymol.sourceforge.net). Intermolecular contact atoms were identiﬁed using
CONTACT in CCP4i53 and electrostatic surface potentials were calculated using
APBS54. Cutaway models were prepared with UCSF Chimera55.
SAXS data collection and processing. SEC-SAXS data were obtained at the BL-
10C, Photon Factory (Tsukuba, Japan). An Acquity HPLC system of UPLC H-
Class system (Waters) with the Superdex 200 Increase 10/300 GL (GE Healthcare)
was utilized to isolate MILL2. The column was preequilibrated with 10 mM
HEPES-NaOH, 150 mM NaCl, pH 7.4 buffer. The ﬂow rate during the sample
measurement was set at 0.1 ml min−1. The eluted sample was loaded into a
stainless-steel cell with a H1.5 ×W3.0 × T1.0 mm window size of and a 0.02 mm-
thick quartz glass window and exposed to X-ray and UV-Visible light simulta-
neously in order to evaluate the sample concentration at the X-ray exposed position
correctly. The scattering intensities (I(Q)) were measured in the region of
0.00753 <Q < 0.424 Å−1, where Q = 4π sinθ/λ and λ= 1 Å, at a distance between
sample and detector of 2.009 m. The exposure times and the number of images
were 20 s and 296 images, respectively. These images were recorded on a
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PILATUS3 2M detector (Dectris). Before injection of the sample on the column,
15 images of ﬂowed buffer scattering were collected for background data. The
scattering intensities recorded on the 2D image were azimuthally averaged to
convert the 1D proﬁle and were subtracted from the background intensities by
using SAngler56. The conversion of intensities to an absolute scale was performed
by using water scattering as a standard. Since no concentration dependence was
observed for the whole data, the ﬁve data around the peak derived from MILL2
were averaged as ﬁnal scattering data. The scattering proﬁles obtained from X-ray
crystal structures were calculated using CRYSOL57. The values of the scattering
intensity at zero angle (I(0)) and the radius of gyration (Rg) were obtained by
Guinier analysis (Q × Rg < 1.3) by using AUTORG58.
Tetramer binding assay. cDNAs for MILL1 and MILL2 mutants without stop
codon were generated by PCR. The primer sequences that incorporated PshBI
and BamHI sites to facilitate cloning are shown in Supplementary Table 3. The
PCR products were digested with PshBI/BamHI and ligated to the NdeI/BamHI-
digested pGMT7-birA vector59. Recombinant soluble MILL1-birA/β2m and
MILL2-birA/β2m heterodimers incorporating the C-terminal biotin ligase (BirA)
recognition sequence (GSLHHILDAQKMVWNHR) were prepared by the same
procedure mentioned above. Refolded MILL1-birA/β2m and MILL2-birA/β2m
were biotinylated with BirA enzyme (Avidity). After biotinylation, biotinylated
MILLs were separated from free biotin by size-exclusion chromatography with
SuperdexTM 200 10/300 GL (GE Healthcare). MILL tetramer was produced by
incubating biotinylated MILL/β2m with phycoerythrin (PE)-conjugated strep-
tavidin (Thermo) for 15 min on ice. For surface staining with MILL tetramer,
NIH-3T3 cells (RCB0150, RIKEN Cell Bank) were detached by DPBS(-) sup-
plemented with 5 mM EDTA, and cell suspensions were stained with PE-
conjugated MILL tetramer on ice for 15 min. Stained cells were washed with
DPBS(-) supplemented with 2% FBS and binding of MILL tetramers was ana-
lyzed by ﬂow cytometry.
Heparinase and heparin treatment. For cell surface heparinase treatment, NIH-
3T3 cells were detached by DPBS(-) supplemented with 5 mM EDTA, and treated
with 2 Uml−1 heparinase I and III (Sigma-Aldrich) in DPBS(-) for 60 min at 37 °C.
Cells were then stained with tetramers after washing twice with ice-cold DPBS(-).
For studying effects of heparin on MILL2 binding, detached cells were stained with
MILL2 tetramer in the presence of 10 µg ml−1 heparin (sodium salt, Nacalai
tesque).
Heparin afﬁnity chromatography. Heparin afﬁnity chromatography was per-
formed with a HiTrap Heparin HP column (1 ml, GE Healthcare) on the AKTA
pure system (GE Healthcare). HLA-G protein was overexpressed as inclusion
bodies in E. coli using the pGMT7 HLA-G vector38 and refolded with human β2m
and RIIPRHLQL peptide following the same procedure for MILL2. MILL2 or
HLA-G proteins were loaded on a column equilibrated with 20 mM Tris-HCl (pH
8.0). After washing the column with 20 column volumes of equilibration buffer,
bound proteins were eluted with 20 column volumes of a 0 to 1M NaCl in 20 mM
Tris-HCl (pH 8.0) linear concentration gradient. Flow through/wash and eluted
peak fractions were pooled, concentrated and analyzed by SDS-PAGE. Gels were
stained with CBB-G250 solution.
Data availability
Coordinates and structure factors have been deposited in the Protein Data Bank under
the accession code 6A97. Other data are available from the corresponding author upon
reasonable request.
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